Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07402811 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease

A NA study of Chronic Pain and Sickle Cell Disease, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07402811: Recruiting NA study of Chronic Pain and Sickle Cell Disease, sponsored by University of Illinois at Chicago.

NCT07402811 is a NA study of Chronic Pain and Sickle Cell Disease that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 20 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07402811, a NA study of Chronic Pain and Sickle Cell Disease, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study examines the feasibility and acceptability of a mindfulness-based mobile intervention designed to support pain and sleep management among adolescents and young adults with sickle cell disease. Chronic pain and sleep problems are common in this population and can negatively affect daily functioning and quality of life. Participants will use a smartphone-based mindfulness program that includes structured modules and guided mindfulness exercises over an approximately 8-week period. The study aims to evaluate whether the intervention is feasible and acceptable for adolescents and young adults with sickle cell disease.

Primary Outcome

Percentage of enrolled participants who remain in the study through the 8-week intervention period

Interventions

  • BEHAVIORAL Mobile bindfulness-based intervention

Study Locations (1)

Illinois

  • University of Illinois Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-12-06
Est. Completion 2026-05
Phase NA
University of Illinois at Chicago

430 total trials

What NCT07402811 shows while recruiting

NCT07402811 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Mobile bindfulness-based intervention is the first listed.

NCT07402811 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT07402811 about?

NCT07402811 is a clinical study titled "Mindfulness-Based Intervention for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease". This study examines the feasibility and acceptability of a mindfulness-based mobile intervention designed to support pain and sleep management among adolescents and young adults with sickle cell disease. Chronic pain and sleep problems are common in this population and can negatively affect daily fu...

What is the current status of trial NCT07402811?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-12-06. Estimated completion is 2026-05.

What conditions does trial NCT07402811 study?

This clinical trial studies the following conditions: Chronic Pain, Sickle Cell Disease, Sleep Disturbance.

What interventions are being tested in trial NCT07402811?

The interventions under investigation include: Mobile bindfulness-based intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07402811?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07402811 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07402811's enrollment target sits among peer trials

20 271st of 301 higher than 28 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07402811, the US trial registry maintained by the National Library of Medicine. NCT07402811 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.